This is the time of year when everyone puts out their lists of the best and worst of the last 12 months. The best movies (”Guardians of the Galaxy”, “The Grand Budapest Hotel”) the worst movies (“Guardians of the Galaxy”, “The Grand Budapest Hotel” – it’s all a matter of taste really) the best music … Continue reading How stem cells made the list of scientific breakthroughs of 2014 (twice actually)
Diabetes
Stem Cell Stories that Caught Your Eye: The Most Popular Stem Cellar Stories of 2014
2014 marked an extraordinary year for regenerative medicine and for CIRM. We welcomed a new president, several of our research programs have moved into clinical trials—and our goal of accelerating treatments for patients in need is within our grasp. As we look back we’d like to revisit The Stem Cellar’s ten most popular stories of … Continue reading Stem Cell Stories that Caught Your Eye: The Most Popular Stem Cellar Stories of 2014
Stem cell stories that caught our eye: two new approaches to treating diabetes and a video on why this work excites
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Insulin producing cells avoid immune rejection. The phrase, there is more than one way to skin a cat often applies to the science of trying … Continue reading Stem cell stories that caught our eye: two new approaches to treating diabetes and a video on why this work excites
10 Years/10 Therapies: 10 Years after its Founding CIRM will have 10 Therapies Approved for Clinical Trials
In 2004, when 59 percent of California voters approved the creation of CIRM, our state embarked on an unprecedented experiment: providing concentrated funding to a new, promising area of research. The goal: accelerate the process of getting therapies to patients, especially those with unmet medical needs. Having 10 potential treatments expected to be approved for … Continue reading 10 Years/10 Therapies: 10 Years after its Founding CIRM will have 10 Therapies Approved for Clinical Trials
What everybody needs to know about CIRM: where has the money gone
It’s been almost ten years since the voters of California created the Stem Cell Agency when they overwhelmingly approved Proposition 71, providing us $3 billion to help fund stem cell research. In the last ten years we have made great progress – we will have ten projects that we are funding in or approved to … Continue reading What everybody needs to know about CIRM: where has the money gone
Moving one step closer to a therapy for type 1 diabetes
When I was a medical journalist one word I always shied away from was “breakthrough”. There are few true breakthroughs in medicine. Usually any advance is the result of years and years of work. That’s why good science takes time; it takes hundreds of small steps to make a giant leap forward. Today we took … Continue reading Moving one step closer to a therapy for type 1 diabetes
Scientists Reach Yet Another Milestone towards Treating Type 1 Diabetes
There was a time when having type 1 diabetes was equivalent to a death sentence. Now, thanks to advances in science and medicine, the disease has shifted from deadly to chronic. But this shift, doctors argue, is not good enough. The disease still poses significant health risks, such as blindness and loss of limbs, as … Continue reading Scientists Reach Yet Another Milestone towards Treating Type 1 Diabetes
Stories of Hope: Diabetes
This week on The Stem Cellar we feature some of our most inspiring patients and patient advocates as they share, in their own words, their Stories of Hope. The last thing Maria Torres expected was to be diagnosed with type 2 diabetes. She exercised, ate well and kept her weight under control. There had to … Continue reading Stories of Hope: Diabetes
World’s largest pharmaceutical company signs deal with ViaCyte supporting stem cell therapy for type 1 diabetes
It’s been a good week for ViaCyte, a good week for us here at the stem cell agency and potentially a great week for people with type 1 diabetes.Earlier this week ViaCyte announced they have been given approval to start a clinical trial for their new approach to treating type 1 diabetes. Then today they announced … Continue reading World’s largest pharmaceutical company signs deal with ViaCyte supporting stem cell therapy for type 1 diabetes
Stem Cell Agency Funded Treatment for Type 1 Diabetes Takes a Big Step towards Clinical Trials
Even the best ideas can fail without a lot of support. One of the things we pride ourselves on at the Stem Cell Agency is nurturing really promising ideas for new therapies through sustained funding, giving them the support they need to turn that promise into reality. So it’s very gratifying today to hear that … Continue reading Stem Cell Agency Funded Treatment for Type 1 Diabetes Takes a Big Step towards Clinical Trials
The Stem Cellar 